MedTrace Logo

Role of Prophylactic Metoclopramide With Tramadol in Trauma Patients

NCT03383315 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 191

Last updated 2017-12-26

No results posted yet for this study

Summary

Tramadol is widely used as analgesic in trauma patients. However, it causes side effects, most notably nausea and vomiting. This study aim to determine the role of prophylactic metoclopramide in preventing tramadol induced nausea and vomiting.

Conditions

  • Trauma
  • Opioid Analgesic Adverse Reaction

Interventions

DRUG

Tramadol

One dose of intravenous tramadol 50mg

DRUG

Metoclopramide

One dose of intravenous metoclopramide 10mg

DRUG

Placebo

Sodium chloride 0.9%

Sponsors & Collaborators

  • University of Malaya

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2017-09-30
Completion
2017-09-30

Countries

  • Malaysia

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03383315 on ClinicalTrials.gov